Literature DB >> 8290165

Thallium myocardial perfusion tomography using intravenous dipyridamole combined with maximal dynamic exercise.

D J Pennell1, S Mavrogeni, C Anagnostopoulos, P J Ell, S R Underwood.   

Abstract

Exercise thallium imaging is effective and provides information on exercise tolerance and symptoms, but is less sensitive if exercise is submaximal. When dipyridamole alone is used for such patients, the exercise parameters are lost and high background uptake results. This study examines dipyridamole combined with maximal exercise, to capitalize on the strengths of both techniques. Thallium tomography was performed in 122 patients with dipyridamole (group 1), exercise (group 2), or dipyridamole with maximum exercise (group 3). In patients with coronary artery disease, thallium tomography was abnormal in 92, 93 and 95% (P = ns), with reversible ischaemia in 82, 81 and 84% (P = ns) in the three groups, respectively. Among patients in groups 2 and 3 who exercised submaximally, detection of individual arterial stenoses was improved in group 3 (P < 0.05) and larger defects were found (2.4 versus 4.2 segments, P < 0.01). In group 3, no serious complications occurred and fewer vasodilatory side effects were seen than in group 1 (P < 0.01). The heart to splanchnic count ratio in groups 2 and 3 (1.61 versus 1.65, P = ns) was significantly greater than in group 1 (1.28, P < 0.0001). Compared with exercise alone, additional dipyridamole improved diagnostic accuracy in patients with limited exercise potential. Compared with dipyridamole alone, additional exercise provided useful exercise information, reduced vasodilatory side effects and improved scan quality. Combined dipyridamole and exercise stress is safe, and could be used routinely, but a larger study is required to establish if there is an overall diagnostic improvement.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8290165     DOI: 10.1097/00006231-199311000-00002

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  4 in total

1.  Safety and feasibility of atropine added to submaximal exercise stress testing with Tl-201 SPECT for the diagnosis of myocardial ischemia.

Authors:  Sanjay K Prasad; Dudley J Pennell
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

2.  Symptom-limited exercise combined with dipyridamole stress: prognostic value in assessment of known or suspected coronary artery disease by use of gated SPECT imaging.

Authors:  Alan W Ahlberg; Sarkis B Baghdasarian; Haris Athar; Jeffrey P Thompsen; Deborah M Katten; Gavin L Noble; Igor Mamkin; Anuj R Shah; Ivette A Leka; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

3.  Pharmacologic stress perfusion imaging with adenosine: role of simultaneous low-level treadmill exercise.

Authors:  Habib Samady; Frans J Th Wackers; Tammy M Joska; Barry L Zaret; Diwakar Jain
Journal:  J Nucl Cardiol       Date:  2002 Mar-Apr       Impact factor: 5.952

4.  Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study.

Authors:  J Lette; J L Tatum; S Fraser; D D Miller; D D Waters; G Heller; E B Stanton; H S Bom; J Leppo; S Nattel
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.